Pharma Giants Spent $130M+ on Lobbying in 2025 for TrumpRx Drug Pricing Plan
Pharmaceutical companies backing TrumpRx spent over $130 million on federal lobbying in 2025, a 23% surge. Eli Lilly paused its obesity awareness camp...
Pharmaceutical companies backing TrumpRx spent over $130 million on federal lobbying in 2025, a 23% surge. Eli Lilly paused its obesity awareness camp...
President Donald Trump's second term has seen multiple initiatives to reduce prescription drug costs, but results are mixed. While some prices dropped...